Oramed Pharmaceuticals Inc. (ORMP)
NASDAQ·Healthcare·Biotechnology
$3.87
+1.71%
Mkt Cap $129.91M
No analyst coverage available
We don't have analyst ratings or price target data for Oramed Pharmaceuticals Inc. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.